ORKA
Oruka Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$92.51
+1.67%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-11.9%
Return on equity
-11.7%
Return on assets
-13.9%
Return on invested capital
0.00x
Asset turnover
-$100.9M
Cash from operations
$13
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026